Literature DB >> 33968630

Provision of medical health care for adults with congenital heart disease associated with aortic involvement.

Ann-Sophie Kaemmerer1,2, Sebastian Freilinger1, Caroline Andonian1, Peter Ewert1, Kalman Havasi2, Nicole Nagdyman1, Lars Pieper3, Kathrin Nebel1, Lavinia Seidel1, Rhoia Neidenbach1, Attila Nemes2.   

Abstract

BACKGROUND: All patients with congenital heart disease (CHD) are chronically ill from their cardiac disease. Despite the increasing evidence that aortic alterations are becoming relevant, the importance of aortopathy in CHD has long been underestimated. This study was conducted to determine the health status of patients and/or the provision of health services of adults with CHD (ACHD) with manifest aortopathy or at risk thereof.
METHODS: In a questionnaire-based cross-sectional survey, the "real life"-care of ACHD was analysed, comparing patients with risk of developing aortopathy and/or manifest aortopathy.
RESULTS: Of the 563 enrolled ACHD (49.6% female, mean age 35.8±12.1, 18-86 years) 56.8% (n=320) had a risk of developing aortopathy and/or manifest aortopathy. Of the 320 patients at risk, 187 (33.2% of the total number) had a proven aortopathy. Within this subgroup, the basic medical care for CHD-independent medical problems was given by primary medical care providers [family doctors/general practitioners (GP) in 89.4% (n=286), internists in 13.4% (n=43), physicians of another specialty in 2.5% (n=8)]. Almost all primary medical care providers knew about the CHD of their patients. Even for CHD-specific health problems, the basic medical care of risk patients was provided by a family doctor or GP in 56.6% (n=181) and by an internist in 18.4% (n=59). 30.0% (n=96) primarily consulted another specialist, including cardiologists. Only 32.8% of ACHD at risk had ever been referred to a CHD specialist by a GP for cardiac problems related to their CHD. In contrast, the need for advice was high for ACHD with aortopathy and related mainly to physical activity, employment and education, pregnancy, rehabilitation or health and life insurance. Only 35.5% of patients at risk indicated that their information on specific care structures for ACHD was sufficient, and a further 38.1% of patients were aware of patient organizations.
CONCLUSIONS: Even today, aortic involvement in ACHD is an often-overlooked condition, although considerable negative effects on morbidity and mortality exist. As aortopathy gains in importance with increasing age and complexity of CHD, almost all affected ACHD need lifelong medical advice and access to modern, scientifically based care concepts. According to the study-results, primary care providers and also patients are mostly insufficiently informed about the specialized ACHD facilities. The future goal is therefore to create a better awareness of CHD problems among both primary care physicians and the patients concerned. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Congenital heart disease (CHD); adults with congenital heart disease (ACHD); aortopathy; care; follow-up; prevention

Year:  2021        PMID: 33968630      PMCID: PMC8102272          DOI: 10.21037/cdt-20-359

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  26 in total

1.  Challenges posed by adults with repaired congenital heart disease.

Authors:  J K Perloff; C A Warnes
Journal:  Circulation       Date:  2001-05-29       Impact factor: 29.690

Review 2.  Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.

Authors:  Denise van der Linde; Elisabeth E M Konings; Maarten A Slager; Maarten Witsenburg; Willem A Helbing; Johanna J M Takkenberg; Jolien W Roos-Hesselink
Journal:  J Am Coll Cardiol       Date:  2011-11-15       Impact factor: 24.094

3.  Arterial haemodynamics in patients after repair of tetralogy of Fallot: influence on left ventricular after load and aortic dilatation.

Authors:  H Senzaki; Y Iwamoto; H Ishido; T Matsunaga; M Taketazu; T Kobayashi; H Asano; T Katogi; S Kyo
Journal:  Heart       Date:  2007-05-31       Impact factor: 5.994

4.  Extra-cardiac comorbidities or complications in adults with congenital heart disease: a nationwide inpatient experience in the United States.

Authors:  Sandeep Singh; Rupak Desai; Hee Kong Fong; Ashish Sadolikar; Suparn Samani; Hemant Goyal
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

Review 5.  Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part II: infective endocarditis, pulmonary hypertension, pulmonary arterial hypertension and aortopathy.

Authors:  Rhoia Neidenbach; Koichiro Niwa; Oeztekin Oto; Erwin Oechslin; Jamil Aboulhosn; David Celermajer; Joerg Schelling; Lars Pieper; Linda Sanftenberg; Renate Oberhoffer; Fokko de Haan; Michael Weyand; Stephan Achenbach; Christian Schlensak; Dirk Lossnitzer; Nicole Nagdyman; Yskert von Kodolitsch; Hans-Carlo Kallfelz; David Pittrow; Ulrike M M Bauer; Peter Ewert; Thomas Meinertz; Harald Kaemmerer
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

Review 6.  The adult with congenital heart disease: born to be bad?

Authors:  Carole A Warnes
Journal:  J Am Coll Cardiol       Date:  2005-07-05       Impact factor: 24.094

7.  Changing mortality in congenital heart disease.

Authors:  Paul Khairy; Raluca Ionescu-Ittu; Andrew S Mackie; Michal Abrahamowicz; Louise Pilote; Ariane J Marelli
Journal:  J Am Coll Cardiol       Date:  2010-09-28       Impact factor: 24.094

Review 8.  Aortic dilatation and aortopathy in congenital heart diseases.

Authors:  Keyhan Sayadpour Zanjani; Koichiro Niwa
Journal:  J Cardiol       Date:  2012-11-21       Impact factor: 3.159

Review 9.  General Concepts in Adult Congenital Heart Disease.

Authors:  Ferit Onur Mutluer; Alpay Çeliker
Journal:  Balkan Med J       Date:  2018-01-20       Impact factor: 2.021

10.  Aortopathy in Congenital Heart Disease in Adults: Aortic Dilatation with Decreased Aortic Elasticity that Impacts Negatively on Left Ventricular Function.

Authors:  Koichiro Niwa
Journal:  Korean Circ J       Date:  2013-04       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.